Centre Proposes Central Approval for Antimicrobials
· India · Business Standard
The Centre has proposed a new system requiring central approval for all antimicrobials, including those for human and veterinary use, to address growing concerns about Antimicrobial Resistance (AMR). This move aims to regulate the use of antibiotics more effectively across the country. The proposal suggests that state authorities will no longer be able to grant manufacturing licenses for these drugs independently. This centralisation is intended to strengthen oversight and combat the spread of drug-resistant infections.
Why it matters
This policy change could significantly impact pharmaceutical manufacturers and the healthcare sector by centralising drug approval processes. It aims to curb AMR, which poses a major public health threat by making infections harder to treat.
Read the original report — Business Standard
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.